(Q33714230)

28 July 2017

1 reference

title

Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials (English)

1 reference

ORCID Public Data File 2021

28 July 2017

1 reference

1 reference

1 reference

author name string

Li RC

series ordinal

1

1 reference

28 July 2017

Zhu M

series ordinal

2

1 reference

28 July 2017

Schentag JJ

series ordinal

3

1 reference

28 July 2017

language of work or name

1 reference

1 July 1999

1 reference

Clinical Pharmacokinetics

28 July 2017

1 reference

28 July 2017

37

1 reference

28 July 2017

1-16

1 reference

28 July 2017

1

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199937010-00001

28 July 2017

0 references

cites work

Once versus thrice daily gentamicin in patients with serious infections

1 reference

12 December 2020

Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model

1 reference

12 December 2020

Two compartment kinetic model with multiple artificial capillary units

1 reference

12 December 2020

Performance of the fractional maximal effect method: comparative interaction studies of ciprofloxacin and protein synthesis inhibitors.

1 reference

12 December 2020

Mathematical Examination of Dual Individualization Principles (I): Relationships between AUC above MIC and Area under the Inhibitory Curve for Cefmenoxime, Ciprofloxacin, and Tobramycin

1 reference

12 December 2020

Impact of pharmacokinetics on the postantibiotic effect exhibited by Pseudomonas aeruginosa following tobramycin exposure: application of an in-vitro model

1 reference

12 December 2020

Inactivation of antibiotics and the dissemination of resistance genes

1 reference

12 December 2020

The theory and relevance of continuous culture

1 reference

12 December 2020

Impact of dosage regimens on the efficacy of piperacillin against Pseudomonas aeruginosa in neutropenic mice

1 reference

12 December 2020

Mathematical model for comparison of time-killing curves

1 reference

12 December 2020

Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response

1 reference

12 December 2020

The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents

1 reference

12 December 2020

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

1 reference

12 December 2020

Influence of protein binding on therapeutic efficacy of cefoperazone

1 reference

12 December 2020

Advantages and disadvantages of an in-vitro model with two compartments connected by a dialyser: results of experiments with ciprofloxacin.

1 reference

12 December 2020

The fractional inhibitory concentration (FIC) index as a measure of synergy

1 reference

12 December 2020

Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model

1 reference

12 December 2020

Mechanistic investigation of the reduction in antimicrobial activity of ciprofloxacin by metal cations.

1 reference

12 December 2020

Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy

1 reference

12 December 2020

Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin

1 reference

12 December 2020

Application of in-vitro models: development of resistance.

1 reference

12 December 2020

In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa

1 reference

12 December 2020

In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.

1 reference

12 December 2020

A new approach to in vitro comparisons of antibiotics in dynamic models: equivalent area under the curve/MIC breakpoints and equiefficient doses of trovafloxacin and ciprofloxacin against bacteria of similar susceptibilities

1 reference

12 December 2020

Correlation between bactericidal activity and postantibiotic effect for five antibiotics with different mechanisms of action.

1 reference

12 December 2020

Bactericidal Activity of Cephalosporins in an In Vitro Model Simulating Serum Levels

1 reference

12 December 2020

An in vitro model for monitoring bacterial responses to antibiotic agents under simulated in vivo conditions

1 reference

12 December 2020

Relationship Between Aminoglycoside-Induced Nephrotoxicity and Auditory Toxicity

1 reference

12 December 2020

Antibiotic kinetics and dynamics for the clinician.

1 reference

12 December 2020

Antibiotic exposure and its relationship to postantibiotic effect and bactericidal activity: constant versus exponentially decreasing tobramycin concentrations against Pseudomonas aeruginosa

1 reference

12 December 2020

Historical review of in-vitro models

1 reference

12 December 2020

Simultaneous pharmacodynamic analysis of the lag and bactericidal phases exhibited by beta-lactams against Escherichia coli

1 reference

12 December 2020

Antimicrobial resistance issues of the future

1 reference

12 December 2020

Markedly different rates and resistance profiles exhibited by seven commonly used and newer beta-lactams on the selection of resistant variants of Enterobacter cloacae

1 reference

12 December 2020

Differences between in vitro and in vivo studies

1 reference

12 December 2020

Mathematical examination of dual individualization principles (II): The rate of bacterial eradication at the same area under the inhibitory curve is more rapid for ciprofloxacin than for cefmenoxime.

1 reference

12 December 2020

Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis

1 reference

12 December 2020

Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man.

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

12 December 2020

Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin

1 reference

12 December 2020

Experimental efficacy of combined ceftriaxone and amoxycillin on penicillin-resistant and broad-spectrum cephalosporin-resistant Streptococcus pneumoniae infection.

1 reference

12 December 2020

Chromosomal beta-lactamase expression and antibiotic resistance in Enterobacter cloacae

1 reference

12 December 2020

Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypotheses

1 reference

12 December 2020

Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections

1 reference

12 December 2020

Gentamicin blood levels: a guide to nephrotoxicity

1 reference

12 December 2020

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

1 reference

12 December 2020

The ability of beta-lactam antibiotics to select mutants with derepressed beta-lactamase synthesis from Citrobacter freundii

1 reference

12 December 2020

Kinetics of antimicrobial action

1 reference

12 December 2020

Artifacts in dilution pharmacokinetic models caused by adherent bacteria

1 reference

12 December 2020

Kinetics and mechanisms of action of drugs on microorganisms. VII. Quantitative adherence of sulfonamide action on microbial growth to a receptor-site model.

1 reference

12 December 2020

New In Vitro Model to Study the Effect of Antibiotic Concentration and Rate of Elimination on Antibacterial Activity

1 reference

12 December 2020

Pharmacodynamic modeling of bacterial kinetics: beta-lactam antibiotics against Escherichia coli.

1 reference

12 December 2020

In vivo postantibiotic effect in a thigh infection in neutropenic mice

1 reference

12 December 2020

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

1 reference

12 December 2020

Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic modeling of the antibiotic effect of piperacillin in vitro

1 reference

12 December 2020

Microbial kinetics of beta-lactam antibiotics against Escherichia coli.

1 reference

12 December 2020

Significance of Serum Protein and Tissue Binding of Antimicrobial Agents

1 reference

12 December 2020

Antimicrobial Resistance in Hospital Organisms and Its Relation to Antibiotic Use

1 reference

12 December 2020

Mathematical examination of dual individualization principles. (III): Development of a scoring system for pneumonia staging and quantitation of response to antibiotics: results in cefmenoxime-treated patients

1 reference

12 December 2020

Once-daily versus multiple-daily dosing of aminoglycosides

1 reference

12 December 2020

Kinetic analysis and characterization of the bacterial regrowth after treatment of Escherichia coli with beta-lactam antibiotics

1 reference

12 December 2020

Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections.

1 reference

12 December 2020

The pharmacodynamics of aminoglycosides

1 reference

12 December 2020

In-vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives.

1 reference

12 December 2020

Microbial pharmacodynamics of piperacillin in neutropenic mice of systematic infection due to Pseudomonas aeruginosa

1 reference

12 December 2020

AUIC--the universal parameter within the constraint of a reasonable dosing interval

1 reference

12 December 2020

The fractional maximal effect method: a new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactions

1 reference

12 December 2020

Differences between bacteria grown in vitro and in vivo

1 reference

12 December 2020

Prevention of drug access to bacterial targets: permeability barriers and active efflux

1 reference

12 December 2020

The postantibiotic effect: a review of in vitro and in vivo data

1 reference

12 December 2020

Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins

1 reference

12 December 2020

Simultaneous simulation of two different concentration time curves in vitro.

1 reference

12 December 2020

Microbial Kinetics and Dependencies of Individual and Combined Antibiotic Inhibitors of Protein Biosynthesis

1 reference

12 December 2020

10.2165/00003088-199937010-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference